In the complex world of retinal research, study coordinators are the steady hands guiding the process from behind the scenes. At InFocus Clinical Research, we know firsthand how essential it is for study coordinators and CROs to work together seamlessly—not just for efficiency and protocol compliance, but to ensure patients are truly cared for throughout the trial journey.

In the fast-paced world of clinical research, study coordinators juggle multiple responsibilities—managing protocols, handling regulatory documents, overseeing patient visits, and ensuring timely data entry. With so many moving parts, time management is not just a skill; it’s a necessity.

In the world of retinal research, study coordinators are the unsung heroes working behind the scenes to ensure clinical trials run smoothly. Their role is multifaceted, requiring them to balance regulatory requirements, manage patient data with precision, ensure strict protocol compliance, and maintain seamless communication with investigators and sponsors. To gain deeper insights into what makes these professionals so effective, InFocus Clinical Research collaborated with some of the top retina research study coordinators globally.

At InFocus Clinical Research, we proudly celebrate the Top Study Coordinators in Retina Clinical Research for 2024. Recognized by our CRAs for their expertise and dedication, these coordinators drive the success of clinical trials.

Brad Doerschuk, InFocus CEO, said, “Study Coordinators ensure quality, timely development of therapeutics. Their dedication is vital to conquering vision-threatening disorders.”

The field of ophthalmology is undergoing a transformative change thanks to innovative retinal clinical trials. With the incidence rate of eye disorders, particularly retinal diseases, continuing to climb in populations worldwide, these trials are becoming the bedrock for new treatment modalities. This article aims to shed light on how retinal clinical trials are revolutionizing the way we approach and treat eye diseases.

Choosing the right Clinical Research Organization (CRO) is a critical decision for any pharmaceutical company. The selected CRO can significantly impact the success of your clinical trials and, ultimately, the time-to-market for your drug candidates. But with a sea of options, what should you focus on when evaluating a CRO? Here are key considerations to ensure you make the best choice: